Employing a Connected, Integrated Alternative to Continuous Bioprocessing

In the latest publication of Genetic Engineering News, our MaruX platform is discussed; our novel, connected and integrated approach to biomanufacturing, a platform for the production of monoclonal antibodies and other recombinant proteins. To read the entire article, click button below.